You're Protecting Your Skin and Still Getting Melasma. Here's Why.

Filaggrin is a structural protein that forms the outermost layer of your skin, the stratum corneum. Think of it as the mortar holding the bricks of your skin cells together. This protein breaks down into amino acids that maintain skin hydration and pH balance, creating a protective barrier against environmental stressors, including UV radiation.

Loss-of-function variants in FLG, the most common being R501X and 2282del4, impair the production of functional filaggrin. Roughly 10% of people with European ancestry carry these variants. The consequence is straightforward: your skin barrier is compromised from birth, allowing UV rays to penetrate deeper into living skin cells where they cause oxidative damage and trigger melanocyte activity. A weakened barrier also permits water loss, leading to dry, inflamed skin that signals for melanin production as a protective response.

You experience this as chronically dry skin, sensitivity to products, redness that lingers after sun exposure, and melasma that appears despite good sun protection. Your skin feels reactive. Barriers that work in other people don’t seem to protect you. UV exposure leaves you with visible inflammation hours later.

Vitamin D receptor is the cellular switch that activates your skin’s innate immune defense system and regulates antimicrobial peptides. When sunlight hits your skin, it triggers vitamin D synthesis, which activates VDR in skin cells, which then upregulates antioxidant enzymes and calms inflammatory signaling. VDR is essential for maintaining skin homeostasis and controlling melanocyte behavior.

Common variants in VDR (BsmI, FokI) reduce the receptor’s sensitivity to vitamin D signaling. Roughly 30-50% of people carry functional variants. This means your skin cells don’t receive the full anti-inflammatory, antioxidant signal that vitamin D should provide, leaving your skin more vulnerable to oxidative stress and inflammation after UV exposure. Your melanocytes remain in a heightened state of reactivity, producing pigment even with moderate sun exposure.

You experience this as melasma that develops despite adequate sun protection, difficulty resolving skin inflammation, and melasma that worsens in seasons when you get less sun (counterintuitively). Your skin feels like it’s overreacting to UV exposure that other people tolerate without darkening.

MTHFR encodes an enzyme central to the methylation cycle, the metabolic pathway that recycles antioxidants like glutathione and generates the methyl groups needed for DNA repair and cellular regeneration. When your skin is exposed to UV radiation, oxidative stress accumulates rapidly. Your cells need a robust methylation cycle to neutralize free radicals and repair damaged DNA before it signals melanocyte activation.

The C677T variant in MTHFR, carried by roughly 40% of the population, reduces enzyme efficiency by 40-70%. This means your cells convert B vitamins into active forms at a fraction of the normal rate, and your ability to recycle antioxidants and repair sun damage is significantly impaired. After UV exposure, free radicals linger longer, perpetuating oxidative stress and chronic inflammation in skin cells. Melanocytes stay activated longer, producing more pigment.

You experience this as melasma that develops after even brief sun exposure, difficulty healing from skin injuries or procedures, and melasma that worsens with stress or poor sleep (both deplete methylation capacity further). Your skin seems to age faster than your peers, with persistent inflammation.

SOD2 (superoxide dismutase 2) is the primary antioxidant enzyme inside mitochondria, the energy-producing organelles in every skin cell. When UV light hits your skin, it generates reactive oxygen species (free radicals) at the mitochondrial level. SOD2 is the first line of defense, converting these highly reactive radicals into less harmful hydrogen peroxide. Without robust SOD2 function, free radicals accumulate unchecked, damaging cellular structures and triggering inflammatory signaling.

The Val16Ala variant in SOD2, present in roughly 40% of the population as homozygous carriers, reduces the enzyme’s efficiency in neutralizing mitochondrial free radicals. This means UV exposure causes disproportionate oxidative stress inside your skin cells, triggering a cascade of inflammatory signals that activate melanocytes and perpetuate melasma. The oxidative stress also damages the skin barrier itself, making it more permeable and reactive.

You experience this as melasma that gets worse during summer or after sun exposure (even with sunscreen), skin that feels inflamed or irritated chronically, and difficulty achieving clear skin despite good skincare routines. Your skin shows signs of accelerated aging: fine lines, loss of firmness, and persistent redness.

TNF-alpha (tumor necrosis factor-alpha) is a master inflammatory cytokine produced by skin immune cells, fibroblasts, and melanocytes themselves. In healthy skin, TNF-alpha surges briefly in response to acute injury or infection, then resolves. But in people with TNF variants, baseline TNF-alpha production is elevated, creating a state of chronic low-grade inflammation that persists even without active injury. This chronic inflammatory state keeps melanocytes signaled to produce protective pigment.

The -308G>A variant in the TNF promoter, carried by roughly 30% of people with European ancestry, increases TNF-alpha production. This means your skin exists in a state of chronic inflammation that amplifies the melanocyte response to any UV exposure, no matter how brief or protected. Even after the sun exposure ends, TNF-alpha signals continue, perpetuating melasma production. The chronic inflammation also impairs skin barrier function and accelerates skin aging.

You experience this as melasma that seems to worsen over time, skin that looks red or inflamed even when you’re not in the sun, and melasma that spreads despite aggressive sun avoidance. Your skin might also show signs of other inflammatory conditions: rosacea-like flushing, sensitivity to skincare products, or a history of eczema or dermatitis.

Interleukin-6 is a cytokine that amplifies inflammatory responses. When your skin is injured or exposed to UV, IL-6 is released to signal immune cells and initiate repair. But IL-6 also activates melanocytes directly, signaling them to produce pigment as a protective response. In people with high IL-6 production, this amplification becomes excessive, turning a minor UV exposure into a disproportionate inflammatory response and melanin surge.

The -174G>C variant in the IL6 promoter, present in roughly 40% of the population carrying the C allele, increases IL-6 production. This means your skin mounts an exaggerated inflammatory response to routine UV exposure, amplifying the melanocyte signal far beyond what the actual UV damage warrants. IL-6 also cross-talks with TNF-alpha, creating a feedback loop where inflammation perpetuates inflammation, and melasma deepens over time.

You experience this as melasma that seems disproportionate to your sun exposure, inflammation that lingers long after sun exposure ends, and melasma that worsens with stress, poor sleep, or illness (all IL-6 triggers). You might notice that melasma flares coincide with times of systemic inflammation or infection.